Stanisław Szlufik

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 177 citations · Full text

Inflammatory cytokines and NT-proCNP in Parkinson’s disease patients

Dariusz Koziorowski, Ryszard Tomasiuk, Stanisław Szlufik et al. · Cytokine · 2012 · 132 citations

Inflammation, Neurodegenerative Diseases, Inflammatory Cytokines +8

Higher cerebrospinal fluid to plasma ratio of p-cresol sulfate and indoxyl sulfate in patients with Parkinson’s disease

Bartłomiej Sankowski, Karolina Księżarczyk, Emilia Raćkowska et al. · Clinica Chimica Acta · 2019 · 104 citations · Full text

Serum amino acid profile in patients with Parkinson’s disease

Monika Figura, Katarzyna Kuśmierska, Ewelina Bucior et al. · PLoS ONE · 2018 · 103 citations · Full text

Neurodegenerative Diseases, Amino Acids, Biochemistry +13

Small intestine dysfunction in Parkinson’s disease

Justyna Dutkiewicz, Stanisław Szlufik, Michał Nieciecki et al. · Journal of Neural Transmission · 2015 · 41 citations · Full text

Health Sciences, Medical Imaging, Parkinson Disease +13